Across TCGA pan-cancer cohorts, TRBJ2-2 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of TRBJ2-2’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where TRBJ2-2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TRBJ2-2 is over-expressed in tumor, although a few such as LUSC and BLCA show the opposite, repressed pattern.
KIRC, LUSC, and BLCA are the cancer types where TRBJ2-2 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TRBJ2-2 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.